APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeted NGS Amplicon Sequencing Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Targeted NGS Amplicon Sequencing Services Market Analysis and Forecast 2026-2032

12 August 2026197 pages

Choose your research edition.

Industry ResearchTargeted NGS Amplicon Sequencing Services Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted NGS Amplicon Sequencing Services Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Targeted NGS Amplicon Sequencing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted NGS Amplicon Sequencing Services Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted NGS Amplicon Sequencing Services Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Targeted NGS Amplicon Sequencing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Targeted NGS Amplicon Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Targeted NGS Amplicon Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Targeted NGS Amplicon Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Targeted NGS Amplicon Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Targeted NGS Amplicon Sequencing Services include Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic, CD Genomics, AllGenetics, Charles River and Source BioScience, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Targeted NGS Amplicon Sequencing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Targeted NGS Amplicon Sequencing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Targeted NGS Amplicon Sequencing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Targeted NGS Amplicon Sequencing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Targeted NGS Amplicon Sequencing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Targeted NGS Amplicon Sequencing Services revenue, projected growth trends, production technology, application and end-user industry.

Targeted NGS Amplicon Sequencing Services Segment by Company

Novogene

BGI (BGI Genomics)

Macrogen

Psomagen

SeqMatic

CD Genomics

AllGenetics

Charles River

Source BioScience

AGRF

Plasmidsaurus

Eurofins Scientific

Charles River Laboratories

ABM

Zymo Research

Paragon Genomics

Quintara Bio

HyLabs

MUGTC

SeqCoast Genomics

Shanghai Baiqu Biomedical Technology

Illumina

Guangzhou IGE Biotechnology

IDT

Azenta Life Sciences

Eurofins Genomics

Targeted NGS Amplicon Sequencing Services Segment by Type

Single-Gene Sequencing

Multi-Gene Panel Sequencing

Customized Region Sequencing

Targeted NGS Amplicon Sequencing Services Segment by Application

Clinical Molecular Diagnostics

Human Genetics & Population Research

Agricultural Biotechnology & Breeding

Industrial Biotechnology

Others

Targeted NGS Amplicon Sequencing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted NGS Amplicon Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted NGS Amplicon Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted NGS Amplicon Sequencing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Targeted NGS Amplicon Sequencing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Targeted NGS Amplicon Sequencing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted NGS Amplicon Sequencing Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single-Gene Sequencing Major Player Table 3. Multi-Gene Panel Sequencing Major Player Table 4. Customized Region Sequencing Major Player Table 5. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinical Molecular Diagnostics Major Player Table 7. Human Genetics & Population Research Major Player Table 8. Agricultural Biotechnology & Breeding Major Player Table 9. Industrial Biotechnology Major Player Table 10. Others Major Player Table 11. Targeted NGS Amplicon Sequencing Services Industry Trends Table 12. Targeted NGS Amplicon Sequencing Services Industry Drivers Table 13. Targeted NGS Amplicon Sequencing Services Industry Opportunities and Challenges Table 14. Targeted NGS Amplicon Sequencing Services Industry Restraints Table 15. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Targeted NGS Amplicon Sequencing Services Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Targeted NGS Amplicon Sequencing Services Market Share by Region (2021-2026) Table 18. Global Targeted NGS Amplicon Sequencing Services Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Targeted NGS Amplicon Sequencing Services Market Share by Region (2027-2032) Table 20. Global Targeted NGS Amplicon Sequencing Services Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Players (2021-2026) Table 22. Global Targeted NGS Amplicon Sequencing Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Targeted NGS Amplicon Sequencing Services Key Players Headquarters & Area Served Table 24. Global Targeted NGS Amplicon Sequencing Services Players, Product Type & Application Table 25. Global Targeted NGS Amplicon Sequencing Services Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Targeted NGS Amplicon Sequencing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Targeted NGS Amplicon Sequencing Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Type (2021-2026) Table 32. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Type (2027-2032) Table 33. Global Targeted NGS Amplicon Sequencing Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Application (2021-2026) Table 37. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Application (2027-2032) Table 38. Novogene Company Information Table 39. Novogene Business Overview Table 40. Novogene Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Novogene Targeted NGS Amplicon Sequencing Services Product Portfolio Table 42. Novogene Recent Development Table 43. BGI (BGI Genomics) Company Information Table 44. BGI (BGI Genomics) Business Overview Table 45. BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Product Portfolio Table 47. BGI (BGI Genomics) Recent Development Table 48. Macrogen Company Information Table 49. Macrogen Business Overview Table 50. Macrogen Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Macrogen Targeted NGS Amplicon Sequencing Services Product Portfolio Table 52. Macrogen Recent Development Table 53. Psomagen Company Information Table 54. Psomagen Business Overview Table 55. Psomagen Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Psomagen Targeted NGS Amplicon Sequencing Services Product Portfolio Table 57. Psomagen Recent Development Table 58. SeqMatic Company Information Table 59. SeqMatic Business Overview Table 60. SeqMatic Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. SeqMatic Targeted NGS Amplicon Sequencing Services Product Portfolio Table 62. SeqMatic Recent Development Table 63. CD Genomics Company Information Table 64. CD Genomics Business Overview Table 65. CD Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. CD Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 67. CD Genomics Recent Development Table 68. AllGenetics Company Information Table 69. AllGenetics Business Overview Table 70. AllGenetics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. AllGenetics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 72. AllGenetics Recent Development Table 73. Charles River Company Information Table 74. Charles River Business Overview Table 75. Charles River Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Charles River Targeted NGS Amplicon Sequencing Services Product Portfolio Table 77. Charles River Recent Development Table 78. Source BioScience Company Information Table 79. Source BioScience Business Overview Table 80. Source BioScience Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Source BioScience Targeted NGS Amplicon Sequencing Services Product Portfolio Table 82. Source BioScience Recent Development Table 83. AGRF Company Information Table 84. AGRF Business Overview Table 85. AGRF Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. AGRF Targeted NGS Amplicon Sequencing Services Product Portfolio Table 87. AGRF Recent Development Table 88. Plasmidsaurus Company Information Table 89. Plasmidsaurus Business Overview Table 90. Plasmidsaurus Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Plasmidsaurus Targeted NGS Amplicon Sequencing Services Product Portfolio Table 92. Plasmidsaurus Recent Development Table 93. Eurofins Scientific Company Information Table 94. Eurofins Scientific Business Overview Table 95. Eurofins Scientific Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Eurofins Scientific Targeted NGS Amplicon Sequencing Services Product Portfolio Table 97. Eurofins Scientific Recent Development Table 98. Charles River Laboratories Company Information Table 99. Charles River Laboratories Business Overview Table 100. Charles River Laboratories Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Charles River Laboratories Targeted NGS Amplicon Sequencing Services Product Portfolio Table 102. Charles River Laboratories Recent Development Table 103. ABM Company Information Table 104. ABM Business Overview Table 105. ABM Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. ABM Targeted NGS Amplicon Sequencing Services Product Portfolio Table 107. ABM Recent Development Table 108. Zymo Research Company Information Table 109. Zymo Research Business Overview Table 110. Zymo Research Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Zymo Research Targeted NGS Amplicon Sequencing Services Product Portfolio Table 112. Zymo Research Recent Development Table 113. Paragon Genomics Company Information Table 114. Paragon Genomics Business Overview Table 115. Paragon Genomics Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Paragon Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 117. Paragon Genomics Recent Development Table 118. Quintara Bio Company Information Table 119. Quintara Bio Business Overview Table 120. Quintara Bio Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Quintara Bio Targeted NGS Amplicon Sequencing Services Product Portfolio Table 122. Quintara Bio Recent Development Table 123. HyLabs Company Information Table 124. HyLabs Business Overview Table 125. HyLabs Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. HyLabs Targeted NGS Amplicon Sequencing Services Product Portfolio Table 127. HyLabs Recent Development Table 128. MUGTC Company Information Table 129. MUGTC Business Overview Table 130. MUGTC Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. MUGTC Targeted NGS Amplicon Sequencing Services Product Portfolio Table 132. MUGTC Recent Development Table 133. SeqCoast Genomics Company Information Table 134. SeqCoast Genomics Business Overview Table 135. SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 137. SeqCoast Genomics Recent Development Table 138. Shanghai Baiqu Biomedical Technology Company Information Table 139. Shanghai Baiqu Biomedical Technology Business Overview Table 140. Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Product Portfolio Table 142. Shanghai Baiqu Biomedical Technology Recent Development Table 143. Illumina Company Information Table 144. Illumina Business Overview Table 145. Illumina Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Illumina Targeted NGS Amplicon Sequencing Services Product Portfolio Table 147. Illumina Recent Development Table 148. Guangzhou IGE Biotechnology Company Information Table 149. Guangzhou IGE Biotechnology Business Overview Table 150. Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Product Portfolio Table 152. Guangzhou IGE Biotechnology Recent Development Table 153. IDT Company Information Table 154. IDT Business Overview Table 155. IDT Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. IDT Targeted NGS Amplicon Sequencing Services Product Portfolio Table 157. IDT Recent Development Table 158. Azenta Life Sciences Company Information Table 159. Azenta Life Sciences Business Overview Table 160. Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Product Portfolio Table 162. Azenta Life Sciences Recent Development Table 163. Eurofins Genomics Company Information Table 164. Eurofins Genomics Business Overview Table 165. Eurofins Genomics Targeted NGS Amplicon Sequencing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Eurofins Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 167. Eurofins Genomics Recent Development Table 168. North America Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026) & (US$ Million) Table 169. North America Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032) & (US$ Million) Table 170. North America Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026) & (US$ Million) Table 171. North America Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032) & (US$ Million) Table 172. North America Targeted NGS Amplicon Sequencing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. North America Targeted NGS Amplicon Sequencing Services Revenue by Country (2021-2026) & (US$ Million) Table 174. North America Targeted NGS Amplicon Sequencing Services Revenue by Country (US$ Million) & (2027-2032) Table 175. Europe Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026) & (US$ Million) Table 176. Europe Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032) & (US$ Million) Table 177. Europe Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026) & (US$ Million) Table 178. Europe Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032) & (US$ Million) Table 179. Europe Targeted NGS Amplicon Sequencing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Europe Targeted NGS Amplicon Sequencing Services Revenue by Country (2021-2026) & (US$ Million) Table 181. Europe Targeted NGS Amplicon Sequencing Services Revenue by Country (US$ Million) & (2027-2032) Table 182. China Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026) & (US$ Million) Table 183. China Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032) & (US$ Million) Table 184. China Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026) & (US$ Million) Table 185. China Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026) & (US$ Million) Table 187. Asia Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032) & (US$ Million) Table 188. Asia Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Targeted NGS Amplicon Sequencing Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Targeted NGS Amplicon Sequencing Services Revenue by Region (US$ Million) & (2021-2026) Table 192. Asia Targeted NGS Amplicon Sequencing Services Revenue by Region (US$ Million) & (2027-2032) Table 193. SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Country (2021-2026) & (US$ Million) Table 199. SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Country (US$ Million) & (2027-2032) Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Targeted NGS Amplicon Sequencing Services Image Figure 2. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Targeted NGS Amplicon Sequencing Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single-Gene Sequencing Image Figure 5. Multi-Gene Panel Sequencing Image Figure 6. Customized Region Sequencing Image Figure 7. Global Targeted NGS Amplicon Sequencing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Targeted NGS Amplicon Sequencing Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinical Molecular Diagnostics Image Figure 10. Human Genetics & Population Research Image Figure 11. Agricultural Biotechnology & Breeding Image Figure 12. Industrial Biotechnology Image Figure 13. Others Image Figure 14. Global Targeted NGS Amplicon Sequencing Services Market Size (US$ Million) & (2021-2032) Figure 15. Global Targeted NGS Amplicon Sequencing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Targeted NGS Amplicon Sequencing Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Targeted NGS Amplicon Sequencing Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Targeted NGS Amplicon Sequencing Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Type (2021-2032) Figure 22. Global Targeted NGS Amplicon Sequencing Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Application (2021-2032) Figure 25. North America Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032) Figure 27. North America Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032) Figure 28. North America Targeted NGS Amplicon Sequencing Services Revenue Share by Country (2021-2032) Figure 29. United States Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032) Figure 34. Europe Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032) Figure 35. Europe Targeted NGS Amplicon Sequencing Services Revenue Share by Country (2021-2032) Figure 36. Germany Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032) Figure 46. China Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032) Figure 47. Asia Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032) Figure 49. Asia Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032) Figure 50. Asia Targeted NGS Amplicon Sequencing Services Revenue Share by Region (2021-2032) Figure 51. Japan Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032) Figure 59. SAMEA Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032) Figure 60. SAMEA Targeted NGS Amplicon Sequencing Services Revenue Share by Country (2021-2032) Figure 61. Brazil Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Targeted NGS Amplicon Sequencing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Gene Sequencing
  • Multi-Gene Panel Sequencing
  • Customized Region Sequencing
Applications
  • Clinical Molecular Diagnostics
  • Human Genetics & Population Research
  • Agricultural Biotechnology & Breeding
  • Industrial Biotechnology
  • Others
Companies covered
  • Novogene
  • BGI (BGI Genomics)
  • Macrogen
  • Psomagen
  • SeqMatic
  • CD Genomics
  • AllGenetics
  • Charles River
  • Source BioScience
  • AGRF
  • Plasmidsaurus
  • Eurofins Scientific
  • Charles River Laboratories
  • ABM
  • Zymo Research
  • Paragon Genomics
  • Quintara Bio
  • HyLabs
  • MUGTC
  • SeqCoast Genomics
  • Shanghai Baiqu Biomedical Technology
  • Illumina
  • Guangzhou IGE Biotechnology
  • IDT
  • Azenta Life Sciences
  • Eurofins Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Targeted NGS Amplicon Sequencing Services Market by Type
  3. 1.2.1 Global Targeted NGS Amplicon Sequencing Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single-Gene Sequencing
  5. 1.2.3 Multi-Gene Panel Sequencing
  6. 1.2.4 Customized Region Sequencing
  7. 1.3 Targeted NGS Amplicon Sequencing Services Market by Application
  8. 1.3.1 Global Targeted NGS Amplicon Sequencing Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinical Molecular Diagnostics
  10. 1.3.3 Human Genetics & Population Research
  11. 1.3.4 Agricultural Biotechnology & Breeding
  12. 1.3.5 Industrial Biotechnology
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Targeted NGS Amplicon Sequencing Services Market Dynamics
  1. 2.1 Targeted NGS Amplicon Sequencing Services Industry Trends
  2. 2.2 Targeted NGS Amplicon Sequencing Services Industry Drivers
  3. 2.3 Targeted NGS Amplicon Sequencing Services Industry Opportunities and Challenges
  4. 2.4 Targeted NGS Amplicon Sequencing Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Targeted NGS Amplicon Sequencing Services Market Perspective (2021-2032)
  2. 3.2 Global Targeted NGS Amplicon Sequencing Services Growth Trends by Region
  3. 3.2.1 Global Targeted NGS Amplicon Sequencing Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Targeted NGS Amplicon Sequencing Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Targeted NGS Amplicon Sequencing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Targeted NGS Amplicon Sequencing Services Revenue by Players
  2. 4.1.1 Global Targeted NGS Amplicon Sequencing Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Targeted NGS Amplicon Sequencing Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Targeted NGS Amplicon Sequencing Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Targeted NGS Amplicon Sequencing Services Key Players Headquarters & Area Served
  7. 4.4 Global Targeted NGS Amplicon Sequencing Services Players, Product Type & Application
  8. 4.5 Global Targeted NGS Amplicon Sequencing Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Targeted NGS Amplicon Sequencing Services Market CR5 and HHI
  11. 4.6.3 2025 Targeted NGS Amplicon Sequencing Services Tier 1, Tier 2, and Tier 3
5 Targeted NGS Amplicon Sequencing Services Market Size by Type
  1. 5.1 Global Targeted NGS Amplicon Sequencing Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2032)
  3. 5.3 Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Type (2021-2032)
6 Targeted NGS Amplicon Sequencing Services Market Size by Application
  1. 6.1 Global Targeted NGS Amplicon Sequencing Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2032)
  3. 6.3 Global Targeted NGS Amplicon Sequencing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novogene
  2. 7.1.1 Novogene Company Information
  3. 7.1.2 Novogene Business Overview
  4. 7.1.3 Novogene Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novogene Targeted NGS Amplicon Sequencing Services Product Portfolio
  6. 7.1.5 Novogene Recent Developments
  7. 7.2 BGI (BGI Genomics)
  8. 7.2.1 BGI (BGI Genomics) Company Information
  9. 7.2.2 BGI (BGI Genomics) Business Overview
  10. 7.2.3 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Product Portfolio
  12. 7.2.5 BGI (BGI Genomics) Recent Developments
  13. 7.3 Macrogen
  14. 7.3.1 Macrogen Company Information
  15. 7.3.2 Macrogen Business Overview
  16. 7.3.3 Macrogen Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Macrogen Targeted NGS Amplicon Sequencing Services Product Portfolio
  18. 7.3.5 Macrogen Recent Developments
  19. 7.4 Psomagen
  20. 7.4.1 Psomagen Company Information
  21. 7.4.2 Psomagen Business Overview
  22. 7.4.3 Psomagen Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Psomagen Targeted NGS Amplicon Sequencing Services Product Portfolio
  24. 7.4.5 Psomagen Recent Developments
  25. 7.5 SeqMatic
  26. 7.5.1 SeqMatic Company Information
  27. 7.5.2 SeqMatic Business Overview
  28. 7.5.3 SeqMatic Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 SeqMatic Targeted NGS Amplicon Sequencing Services Product Portfolio
  30. 7.5.5 SeqMatic Recent Developments
  31. 7.6 CD Genomics
  32. 7.6.1 CD Genomics Company Information
  33. 7.6.2 CD Genomics Business Overview
  34. 7.6.3 CD Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CD Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  36. 7.6.5 CD Genomics Recent Developments
  37. 7.7 AllGenetics
  38. 7.7.1 AllGenetics Company Information
  39. 7.7.2 AllGenetics Business Overview
  40. 7.7.3 AllGenetics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AllGenetics Targeted NGS Amplicon Sequencing Services Product Portfolio
  42. 7.7.5 AllGenetics Recent Developments
  43. 7.8 Charles River
  44. 7.8.1 Charles River Company Information
  45. 7.8.2 Charles River Business Overview
  46. 7.8.3 Charles River Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Charles River Targeted NGS Amplicon Sequencing Services Product Portfolio
  48. 7.8.5 Charles River Recent Developments
  49. 7.9 Source BioScience
  50. 7.9.1 Source BioScience Company Information
  51. 7.9.2 Source BioScience Business Overview
  52. 7.9.3 Source BioScience Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Source BioScience Targeted NGS Amplicon Sequencing Services Product Portfolio
  54. 7.9.5 Source BioScience Recent Developments
  55. 7.10 AGRF
  56. 7.10.1 AGRF Company Information
  57. 7.10.2 AGRF Business Overview
  58. 7.10.3 AGRF Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AGRF Targeted NGS Amplicon Sequencing Services Product Portfolio
  60. 7.10.5 AGRF Recent Developments
  61. 7.11 Plasmidsaurus
  62. 7.11.1 Plasmidsaurus Company Information
  63. 7.11.2 Plasmidsaurus Business Overview
  64. 7.11.3 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Product Portfolio
  66. 7.11.5 Plasmidsaurus Recent Developments
  67. 7.12 Eurofins Scientific
  68. 7.12.1 Eurofins Scientific Company Information
  69. 7.12.2 Eurofins Scientific Business Overview
  70. 7.12.3 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Product Portfolio
  72. 7.12.5 Eurofins Scientific Recent Developments
  73. 7.13 Charles River Laboratories
  74. 7.13.1 Charles River Laboratories Company Information
  75. 7.13.2 Charles River Laboratories Business Overview
  76. 7.13.3 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Product Portfolio
  78. 7.13.5 Charles River Laboratories Recent Developments
  79. 7.14 ABM
  80. 7.14.1 ABM Company Information
  81. 7.14.2 ABM Business Overview
  82. 7.14.3 ABM Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ABM Targeted NGS Amplicon Sequencing Services Product Portfolio
  84. 7.14.5 ABM Recent Developments
  85. 7.15 Zymo Research
  86. 7.15.1 Zymo Research Company Information
  87. 7.15.2 Zymo Research Business Overview
  88. 7.15.3 Zymo Research Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Zymo Research Targeted NGS Amplicon Sequencing Services Product Portfolio
  90. 7.15.5 Zymo Research Recent Developments
  91. 7.16 Paragon Genomics
  92. 7.16.1 Paragon Genomics Company Information
  93. 7.16.2 Paragon Genomics Business Overview
  94. 7.16.3 Paragon Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Paragon Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  96. 7.16.5 Paragon Genomics Recent Developments
  97. 7.17 Quintara Bio
  98. 7.17.1 Quintara Bio Company Information
  99. 7.17.2 Quintara Bio Business Overview
  100. 7.17.3 Quintara Bio Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Quintara Bio Targeted NGS Amplicon Sequencing Services Product Portfolio
  102. 7.17.5 Quintara Bio Recent Developments
  103. 7.18 HyLabs
  104. 7.18.1 HyLabs Company Information
  105. 7.18.2 HyLabs Business Overview
  106. 7.18.3 HyLabs Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 HyLabs Targeted NGS Amplicon Sequencing Services Product Portfolio
  108. 7.18.5 HyLabs Recent Developments
  109. 7.19 MUGTC
  110. 7.19.1 MUGTC Company Information
  111. 7.19.2 MUGTC Business Overview
  112. 7.19.3 MUGTC Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 MUGTC Targeted NGS Amplicon Sequencing Services Product Portfolio
  114. 7.19.5 MUGTC Recent Developments
  115. 7.20 SeqCoast Genomics
  116. 7.20.1 SeqCoast Genomics Company Information
  117. 7.20.2 SeqCoast Genomics Business Overview
  118. 7.20.3 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  119. 7.20.4 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  120. 7.20.5 SeqCoast Genomics Recent Developments
  121. 7.21 Shanghai Baiqu Biomedical Technology
  122. 7.21.1 Shanghai Baiqu Biomedical Technology Company Information
  123. 7.21.2 Shanghai Baiqu Biomedical Technology Business Overview
  124. 7.21.3 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Product Portfolio
  126. 7.21.5 Shanghai Baiqu Biomedical Technology Recent Developments
  127. 7.22 Illumina
  128. 7.22.1 Illumina Company Information
  129. 7.22.2 Illumina Business Overview
  130. 7.22.3 Illumina Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Illumina Targeted NGS Amplicon Sequencing Services Product Portfolio
  132. 7.22.5 Illumina Recent Developments
  133. 7.23 Guangzhou IGE Biotechnology
  134. 7.23.1 Guangzhou IGE Biotechnology Company Information
  135. 7.23.2 Guangzhou IGE Biotechnology Business Overview
  136. 7.23.3 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Product Portfolio
  138. 7.23.5 Guangzhou IGE Biotechnology Recent Developments
  139. 7.24 IDT
  140. 7.24.1 IDT Company Information
  141. 7.24.2 IDT Business Overview
  142. 7.24.3 IDT Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  143. 7.24.4 IDT Targeted NGS Amplicon Sequencing Services Product Portfolio
  144. 7.24.5 IDT Recent Developments
  145. 7.25 Azenta Life Sciences
  146. 7.25.1 Azenta Life Sciences Company Information
  147. 7.25.2 Azenta Life Sciences Business Overview
  148. 7.25.3 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Product Portfolio
  150. 7.25.5 Azenta Life Sciences Recent Developments
  151. 7.26 Eurofins Genomics
  152. 7.26.1 Eurofins Genomics Company Information
  153. 7.26.2 Eurofins Genomics Business Overview
  154. 7.26.3 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  156. 7.26.5 Eurofins Genomics Recent Developments
8 North America
  1. 8.1 North America Targeted NGS Amplicon Sequencing Services Revenue (2021-2032)
  2. 8.2 North America Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032)
  5. 8.3 North America Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032)
  9. 8.5 North America Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Targeted NGS Amplicon Sequencing Services Revenue by Country
  11. 8.6.1 North America Targeted NGS Amplicon Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Targeted NGS Amplicon Sequencing Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Targeted NGS Amplicon Sequencing Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Targeted NGS Amplicon Sequencing Services Revenue (2021-2032)
  2. 9.2 Europe Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032)
  5. 9.3 Europe Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032)
  9. 9.5 Europe Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Targeted NGS Amplicon Sequencing Services Revenue by Country
  11. 9.6.1 Europe Targeted NGS Amplicon Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Targeted NGS Amplicon Sequencing Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Targeted NGS Amplicon Sequencing Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Targeted NGS Amplicon Sequencing Services Revenue (2021-2032)
  2. 10.2 China Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2032)
  3. 10.2.1 China Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026)
  4. 10.2.2 China Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032)
  5. 10.3 China Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032)
  6. 10.4 China Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2032)
  7. 10.4.1 China Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026)
  8. 10.4.2 China Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032)
  9. 10.5 China Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Targeted NGS Amplicon Sequencing Services Revenue (2021-2032)
  2. 11.2 Asia Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032)
  5. 11.3 Asia Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032)
  9. 11.5 Asia Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Targeted NGS Amplicon Sequencing Services Revenue by Country
  11. 11.6.1 Asia Targeted NGS Amplicon Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Targeted NGS Amplicon Sequencing Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Targeted NGS Amplicon Sequencing Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Targeted NGS Amplicon Sequencing Services Revenue (2021-2032)
  2. 12.2 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Targeted NGS Amplicon Sequencing Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Targeted NGS Amplicon Sequencing Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Country
  11. 12.6.1 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Targeted NGS Amplicon Sequencing Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst